Home
Portfolio
About
Blog
Contact
>>
Portfolio
>>
Biotech
We partner with leaders to disrupt industries and build enduring companies.
Neuralink
Biotech
Creating a generalized brain interface to restore autonomy to those with unmet medical needs today and unlock human potential tomorrow.
View Company
Milestones
Round Number
17
No decimal points here
Revenue
$42.9bn
Impressive monetary figure
Percentage
96%
The higher the better
We work with investors and shareholders seeking thoughtful late-stage venture secondaries exposure to leading AI and technology companies.
Get in Touch